Drs Peter Higgins and Michael Chiorean discuss risk stratification, monitoring, and treatment of Crohn's disease after surgery. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/9676

Breaking the Therapeutic Ceiling in Crohn's Disease

Aug 23rd, 2022 24m 54s

Drs Peter Higgins and Bram Verstockt discuss breaking the therapeutic ceiling in Crohn's disease and the differential effectiveness of therapies and phenotypes in identifying responses to treatment. Relevant disclosures can be found with the ep

Anti–interleukin-23 Medications and Durable Remission for Patients With Crohn's Disease

Jul 21st, 2022 25m 53s

Drs Peter Higgins and Raja Atreya discuss the phenomenon of durable drug free remission in a subset of patients with Crohn's disease and the future of intermittent induction and sequencing of therapies. Relevant disclosures can be found with th

How Physicians Can Help Patients With Crohn's Disease Navigate Insurance Delays and Denials

Jun 21st, 2022 23m 6s

Drs Peter Higgins and Frank Scott discuss the challenges of delays in care for patients with Crohn's disease, how insurance denials and delays harm patients, and what doctors can do to help. Relevant disclosures can be found with the episode sh

Are We Any Closer to Intestinal Gene Therapy in Crohn's Disease?

May 24th, 2022 20m 59s

Drs Peter Higgins and Judy Cho discuss recent success in sickle cell anemia and whether we're any closer to using intestinal gene therapy in Crohn's disease. Relevant disclosures can be found with the episode show notes on Medscape.com (https:/

Early Risk Markers, Interventions, and Prevention in Crohn's Disease

May 24th, 2022 22m 45s

Drs Peter Higgins and Jean-Frederic Colombel discuss exciting new evidence in Crohn's disease research that may help in identifying those at risk before disease starts and pave the way for a vaccine. Relevant disclosures can be found with the e

Rate